Mark de Groot

4.5k citations

81 papers · 1.6k indexed · h-index 24

Impact in

Toxicology top 5%
- Pharmacovigilance and Adverse Drug Reactions
Health Informatics top 10%

Papers in ⓘ

Cardiology and Cardiovascular Medicine 21
- Cardiovascular Function and Risk Factors 7
Surgery 18

Co-authors: Ulrich O. von Oppell (6 shared papers)Olaf H. Klungel (17 shared papers)A.C. van Grootheest (3 shared papers)Stefan Neubauer (6 shared papers)Saskia Haitjema (16 shared papers)Michael Horn (5 shared papers)Robert F. Reynolds (11 shared papers)H.E. van der Wiel (1 shared paper)
Journals: Pharmacoepidemiology and Drug Safety (6 papers)The Annals of Thoracic Surgery (4 papers)European Journal of Clinical Pharmacology (4 papers)British Journal of Clinical Pharmacology (3 papers)Magnetic Resonance in Medicine (2 papers)
Partner nations: Netherlands Germany United States

In The Last Decade

Mark de Groot

79 papers receiving 1.6k citations

Peers

Countries citing papers authored by Mark de Groot

Since Specialization

Citations

This map shows the geographic impact of Mark de Groot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark de Groot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark de Groot more than expected).

Fields of papers citing papers by Mark de Groot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark de Groot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark de Groot. The network helps show where Mark de Groot may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark de Groot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark de Groot Line = papers co-authored together Mark de Groot links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Treatment to Target Using Recombinant Interleukin‐1 Receptor Antagonist as First‐Line Monotherapy in New‐Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five‐Year Follow‐Up Study Arthritis & Rheumatology ·Nienke M. ter Haar, E. H. Pieter van Dijkhuizen, Joost F. Swart, Annet van Royen‐Kerkhof, Ayman El Idrissi, A. Leek, Wilco de Jager, Mark de Groot, Saskia Haitjema, Dirk Holzinger, Dirk Foell, Jorg van Loosdregt, Nico Wulffraat, Sytze de Roock, Sebastiaan J. Vastert	2019	111
2	Na ⁺ /H ⁺ Exchange Inhibition With HOE642 Improves Postischemic Recovery due to Attenuation of Ca ²⁺ Overload and Prolonged Acidosis on Reperfusion Circulation ·Hinrik Strömer, Mark de Groot, Michael Horn, Christian Faul, Andrea Leupold, James P. Morgan, Wolfgang Scholz, Stefan Neubauer	2000	106
3	Advantages and risks in increasing cyclone separator length AIChE Journal ·Alex C. Hoffmann, Mark de Groot, Weiming Peng, H.W.A. Dries, Jan Kater	2001	89
4	The High Impact of Penicillin Allergy Registration in Hospitalized Patients The Journal of Allergy and Clinical Immunology In Practice ·Savannah M van Dijk, Helga Gardarsdóttir, M.W.M. Wassenberg, Jan Jelrik Oosterheert, Mark de Groot, Heike Röckmann	2016	88
5	Proton pump inhibitor‐induced acute interstitial nephritis British Journal of Clinical Pharmacology ·Linda Härmark, H.E. van der Wiel, Mark de Groot, A.C. van Grootheest	2007	80
6	Pulmonary resection as an adjunct in the treatment of multiple drug-resistant tuberculosis The Annals of Thoracic Surgery ·Marc Van Leuven, Mark de Groot, Karen Shean, Ulrich O. von Oppell, Paul A. Willcox	1997	57
7	Mapping of novel regions of DNA gain and loss by comparative genomic hybridization in esophageal carcinoma in the Black and Colored populations of South Africa. PubMed ·L. du Plessis, E. Dietzsch, Mireille Van Gele, Nadine Van Roy, Paul D. van Helden, M. Iqbal Parker, David Mugwanya, Mark de Groot, Munro P. Marx, Maritha J. Kotze, Frank Speleman	1999	55
8	A Human(e) Factor in Clinical Decision Support Systems Journal of Medical Internet Research ·Tim Bezemer, Mark de Groot, Enja Blasse, Maarten J. ten Berg, Teus H. Kappen, Annelien L. Bredenoord, Wouter W. van Solinge, Imo E. Hoefer, Saskia Haitjema	2019	49
9	Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD) BMJ Open ·Lamiae Grimaldi‐Bensouda, Olaf H. Klungel, Xavier Kurz, Mark de Groot, Ana S.M. Afonso, Marie L. De Bruin, Robert F. Reynolds, Michel Rossignol	2016	46
10	Evaluation of patients’ experiences with antidepressants reported by means of a medicine reporting system European Journal of Clinical Pharmacology ·Erica C.G. van Geffen, S. W. van der Wal, Rolf van Hulten, Mark de Groot, Toine C. G. Egberts, Eibert R. Heerdink	2007	44
11	Penetrating Thoracic Injuries: What We Have Learnt1 The Thoracic and Cardiovascular Surgeon ·Ulrich O. von Oppell, Peter Bautz, Mark de Groot	2000	40
12	Measurement of myocardial infarct size from plasma fatty acid-binding protein or myoglobin, using individually estimated clearance rates Cardiovascular Research ·Mark de Groot	1999	39
13	Antiepileptic drug use in seven electronic health record databases in Europe: A methodologic comparison Epilepsia ·Mark de Groot, Markus Schuerch, Frank de Vries, Ulrik Hesse, Belén Oliva, Miguel Gil, Consuelo Huerta, Gema Requena, Francisco J. de Abajo, Ana S.M. Afonso, Patrick C. Souverein, Yolanda Escobar, Jim Slattery, Marietta Rottenkolber, Sven Schmiedl, Liset van Dijk, Raymond G. Schlienger, Robert F. Reynolds, Olaf H. Klungel	2014	34
14	Multi‐centre, multi‐database studies with common protocols: lessons learnt from the IMI PROTECT project Pharmacoepidemiology and Drug Safety ·Olaf H. Klungel, Xavier Kurz, Mark de Groot, Raymond G. Schlienger, Stéphanie Tcherny‐Lessenot, Lamiae Grimaldi‐Bensouda, Luisa Ibáñez, Rolf H. H. Groenwold, Robert F. Reynolds	2016	33
15	Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS) after Polytrauma: A Rare Syndrome with Major Consequences Journal of Clinical Medicine ·Lillian Hesselink, Ruben J. Hoepelman, Roy Spijkerman, Mark de Groot, Karlijn J. P. van Wessem, Leo Koenderman, Luke P. H. Leenen, Falco Hietbrink	2020	33
16	Effects of ACE inhibition and β-receptor blockade on energy metabolism in rats postmyocardial infarction American Journal of Physiology-Heart and Circulatory Physiology ·Stephanie Hügel, Michael Horn, Mark de Groot, Helga Remkes, Charlotte Dienesch, Kai Hu, Georg Ertl, Stefan Neubauer	1999	32
17	Prospective study of etoposide scheduling in combination chemotherapy for limited disease small cell lung carcinoma European Journal of Cancer and Clinical Oncology ·Raymond P. Abratt, Paul A. Willcox, Mark de Groot, Hillel Goodman, Erika R. Jansen, D. G. Mame Salton	1991	31
18	Tracheobronchial foreign bodies. Experience at Red Cross Children's Hospital, 1985-1990. PubMed ·Anthony Linegar, Ulrich O. von Oppell, Stefan Hegemann, Mark de Groot, John A. Odell	1992	30
19	Detection of myocardial viability based on measurement of sodium content: A ²³Na‐NMR study Magnetic Resonance in Medicine ·Michael P. Horn, Claudia Weidensteiner, Heike Scheffer, Martin Meininger, Mark de Groot, Helga Remkes, Charlotte Dienesch, Karin Przyklenk, Markus von Kienlin, Stefan Neubauer	2001	29
20	Successful management of aortoesophageal fistula due to thoracic aortic aneurysm The Annals of Thoracic Surgery ·Ulrich O. von Oppell, Mark de Groot, Casper Thierfelder, Peter Zilla, John A. Odell	1991	28

About Mark de Groot

Mark de Groot is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Physiology, having authored 81 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (7 papers), Pharmacovigilance and Adverse Drug Reactions (6 papers), Advanced MRI Techniques and Applications (6 papers), Pharmaceutical Practices and Patient Outcomes (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers) and Asthma and respiratory diseases (4 papers). The work is most often cited by research in Toxicology (73 citations), Health Informatics (22 citations), Emergency Medicine (121 citations), Cardiology and Cardiovascular Medicine (263 citations) and Geriatrics and Gerontology (44 citations). Mark de Groot has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Ulrich O. von Oppell, Olaf H. Klungel, A.C. van Grootheest, Stefan Neubauer, Saskia Haitjema, Michael Horn, Robert F. Reynolds, H.E. van der Wiel, Linda Härmark and Jan Jelrik Oosterheert. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, The Annals of Thoracic Surgery, European Journal of Clinical Pharmacology, British Journal of Clinical Pharmacology and Magnetic Resonance in Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact